Beneficial effects of mineralocorticoid receptor blockade in experimental non‐alcoholic steatohepatitis

E-ISSN： 1478-3231|35|9|2129-2138

ISSN： 1478-3223

Source： LIVER INTERNATIONAL (ELECTRONIC), Vol.35, Iss.9, 2015-09, pp. : 2129-2138

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Therapeutic effects of angiotensin II type 1 receptor blocker, irbesartan, on non-alcoholic steatohepatitis using FLS-ob/ob male mice

International Journal of Molecular Medicine, Vol. 30, Iss. 1, 2012-01 ,pp. : 107-113

Spandidos Publications

Access to resources Recommend Favorite

Liraglutide for NASH/NAFLD

HEPATOLOGY RESEARCH, Vol. 45, Iss. 3, 2015-03 ,pp. : 269-278

John Wiley & Sons Inc

Access to resources Recommend Favorite

The soluble guanylate cyclase stimulator IW‐1973 prevents inflammation and fibrosis in experimental non‐alcoholic steatohepatitis

BRITISH JOURNAL OF PHARMACOLOGY (ELECTRONIC), Vol. 175, Iss. 6, 2018-03 ,pp. : 953-967

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinical and metabolic effects associated with weight changes and obeticholic acid in non‐alcoholic steatohepatitis

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 47, Iss. 5, 2018-03 ,pp. : 645-656

John Wiley & Sons Inc

Access to resources Recommend Favorite

Honokiol attenuates diet‐induced non‐alcoholic steatohepatitis by regulating macrophage polarization through activating peroxisome proliferator‐activated receptor γ

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol. 33, Iss. 2, 2018-02 ,pp. : 524-532

John Wiley & Sons Inc

Access to resources Recommend Favorite